Adaptive Biotechnologies financials at a glance

+ Portfolio

The revenue of Adaptive Biotechnologies is reported as 0.17028 billion Dollars in the fiscal year 2023. The earnings were -1.38 Dollars per share in 2023, which was 0.72 higher than 2022. And about -0.16702 billion Dollars are reported as free cash flow in the financials of Adaptive Biotechnologies 2023. No dividends were paid to the shareholders of the Adaptive Biotechnologies stock NasdaqGS:ADPT in the financial year 2023.

$170.28M

Revenue

$-1.38

Earnings Per Share

43.61%

Gross Margin %

$-,116.00M

Free Cash Flow

Revenue

170.28

Earnings Per Share

-1.38

Gross Margin %

43.61

Free Cash Flow

-,116.00

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018
Rev.	Revenue	N/A	$170.28M	$185.31M	$154.34M	$98.38M	$85.07M	$55.66M
GM %	Gross Margin %	-9.31%	43.61%	-7.37%	-24.17%	68.44%	69.19%	-5.68%
OM	Operating Margin	-,107.71%	-,118.40%	-,107.17%	-,135.39%	-,155.33%	-92.15%	-89.39%
EPS	Earnings Per Share	$-1.36	$-1.38	$-1.39	$-1.48	$-1.11	$-1.01	$-0.44
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	0
Sha.	Shares	N/AM	145.09M	143.23M	141.58M	139.22M	126.32M	12.84M
OCF	Operating Cash Flow	N/A	$-,156.32M	$-,183.95M	$-,192.73M	$-,149.68M	$205.40M	$0.00M
FCF	Free Cash Flow	N/A	$-,116.00M	$-,200.29M	$-,254.47M	$-,168.49M	$194.20M	$0.00M
FCFS	Free Cash Flow Per Share	$-1.19	$-1.16	$-1.41	$-1.81	$-1.28	$2.81	$-3.05

Adaptive Biotechnologies financials at a glance

Financials

Discover